Rodica Busui MD PhD
Diabetes, Lipid Metabolism
Professor of Internal Medicine, Metabolism, Endocrinology and Diabetes. Preventative Cardiology
Join to View Full Profile
3181 SW Sam Jackson Park RdPortland, OR 97239
Phone+1 503-494-3273
Fax+1 503-418-2208
Dr. Busui is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2001
University of Medicine and Pharmacy TimisoaraClass of 1987
Certifications & Licensure
MI State Medical License 1997 - 2026
OR State Medical License 2024 - 2025
OH State Medical License 2001 - 2023
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Research Affairs Core Committee Member Endocrine Society, 2020
- Chair, Diabetes and Cardiovascular Complications Interest Group American Diabetes Association, 2018-2020
- Chair, Clinical Research Review American Diabetes Association, 2017-2020
- Join now to see all
Clinical Trials
- Adjunct Collection of Additional Biorepository Data From Patients Enrolled in Diabetic Foot Consortium (DFC) Trials Start of enrollment: 2021 May 01
Roles: Principal Investigator
Publications & Presentations
PubMed
- 6 citationsCardiovascular Autonomic Neuropathy and Risk of Kidney Function Decline in Type 1 and Type 2 Diabetes: Findings From the PERL and ACCORD Cohorts.Yaling Tang, Lynn Ang, Mamta Jaiswal, Brendan R Dillon, Nazanene H Esfandiari
Diabetes. 2024-05-01 - 62 citationsEffects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney...Darren K McGuire, Rodica P Busui, John Deanfield, Silvio E Inzucchi, Johannes F E Mann
Diabetes, Obesity & Metabolism. 2023-07-01 - 119 citationsSafety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.Anders L. Carlson, Jennifer L. Sherr, Dorothy I. Shulman, Satish K. Garg, Rodica Pop-Busui
Diabetes Technology & Therapeutics. 2021-11-16
Press Mentions
NSAIDs Linked to Heart Failure Risk in DiabetesAugust 25th, 2022- Eat Better, Move, but Don’t Worry About DiabetesJune 25th, 2022
- Adjunct Collection of Additional Biorepository Data from Patients Enrolled in Diabetic Foot Consortium (DFC) TrialsOctober 25th, 2021
- Join now to see all
Grant Support
- PERL A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1DNIDDK2013–2018
- Adjunctive versus Replacement Continuous Glucose Monitoring (CGM) RCTHelmsley Trust Foundation2015–2016
- Impact of glycemic variability on cardiovascular autonomic neuropathy and cardiomyopathy in type 1 diabetesAmerican Diabetes Association2014–2016
- Tissue-Specific Metabolic Reprogramming in Diabetic ComplicationsNIDDK2011–2016
- Cardiac Autonomic Neuropathy and Myocardial Dysfunction in Type 1 Diabetes.National Heart Lung Blood Institute2010–2016
Committees
- member, Standards of Medical Care in Diabetes - 2015
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
